Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2159.HK Stock Summary
Top 10 Correlated ETFs
2159.HK
In the News
2159.HK Financial details
Company Rating
Buy
Market Cap
94M
Income
-78.58M
Revenue
297.84M
Book val./share
0.83
Cash/share
0.81
Dividend
-
Dividend %
-
Employees
419
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.88
Forward P/E
-
PEG
0
P/S
0.27
P/B
0.42
P/C
0.62
P/FCF
-3.91
Quick Ratio
1.43
Current Ratio
2.32
Debt / Equity
0.24
LT Debt / Equity
0.05
-
-
EPS (TTM)
-0.43
EPS next Y
-
EPS next Q
-
EPS this Y
-2053.13%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
1.58%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-29%
ROE
-39%
ROC
-0.42%
Gross Margin
10%
Oper. Margin
-27%
Profit Margin
-29%
Payout
-
Shs Outstand
210.53M
Shs Float
94.51M
-
-
-
-
Target Price
-
52W Range
0.36-1.42
52W High
-
52W Low
-
RSI
61
Rel Volume
0.38
Avg Volume
109.11K
Volume
41.6K
Perf Week
17.65%
Perf Month
19.05%
Perf Quarter
-26.47%
Perf Half Y
-21.88%
-
-
-
-
Beta
0.555
-
-
Volatility
0.01%, 0.04%
Prev Close
3.09%
Price
0.5
Change
2.04%
2159.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.49 | 2.14 | 2.16 | 3.91 | 1.74 | |
Net income per share | 0.19 | 0.1 | 0.11 | 0.03 | -0.5 | |
Operating cash flow per share | 0.29 | 0.02 | 0.16 | 0 | -0.1 | |
Free cash flow per share | 0.27 | -0.04 | 0.09 | -0.14 | -0.12 | |
Cash per share | 0.5 | 0.46 | 0.52 | 0.96 | 0.83 | |
Book value per share | 0.59 | 0.68 | 0.81 | 1.56 | 1.05 | |
Tangible book value per share | 0.61 | 0.6 | 0.72 | 1.39 | 0.92 | |
Share holders equity per share | 0.59 | 0.68 | 0.81 | 1.56 | 1.05 | |
Interest debt per share | 0.04 | 0.02 | 0.13 | 0.15 | 0.15 | |
Market cap | 665.15M | 676.82M | 637.86M | 196.69M | 226.43M | |
Enterprise value | 574.01M | 607.34M | 574.29M | 56.55M | 114.34M | |
P/E ratio | 17.48 | 32.46 | 30.31 | 42.35 | -2.42 | |
Price to sales ratio | 2.22 | 1.58 | 1.48 | 0.28 | 0.7 | |
POCF ratio | 11.3 | 149.9 | 20.5 | 750.74 | -12.27 | |
PFCF ratio | 12.39 | -79.8 | 36.85 | -7.95 | -9.95 | |
P/B Ratio | 5.59 | 4.98 | 3.96 | 0.69 | 1.16 | |
PTB ratio | 5.59 | 4.98 | 3.96 | 0.69 | 1.16 | |
EV to sales | 1.92 | 1.42 | 1.33 | 0.08 | 0.35 | |
Enterprise value over EBITDA | 9.83 | 14.29 | 13.99 | 3.19 | -1.71 | |
EV to operating cash flow | 9.76 | 134.52 | 18.45 | 215.83 | -6.19 | |
EV to free cash flow | 10.7 | -71.61 | 33.18 | -2.29 | -5.03 | |
Earnings yield | 0.06 | 0.03 | 0.03 | 0.02 | -0.41 | |
Free cash flow yield | 0.08 | -0.01 | 0.03 | -0.13 | -0.1 | |
Debt to equity | 0.07 | 0.03 | 0.16 | 0.09 | 0.14 | |
Debt to assets | 0.04 | 0.02 | 0.09 | 0.07 | 0.08 | |
Net debt to EBITDA | -1.56 | -1.64 | -1.55 | -7.91 | 1.67 | |
Current ratio | 1.93 | 2.15 | 2.37 | 4.81 | 2.32 | |
Interest coverage | 164.84 | 102.8 | 26.06 | -1.42 | -70.34 | |
Income quality | 1.2 | 0.17 | 1.4 | 0.05 | 0.2 | |
Dividend Yield | 0.02 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.36 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.06 | 0.12 | 0.1 | 0.15 | |
Research and developement to revenue | 0.02 | 0.03 | 0.03 | 0.03 | 0.16 | |
Intangibles to total assets | 0.02 | 0.11 | 0.09 | 0.11 | 0.1 | |
Capex to operating cash flow | -0.09 | -2.88 | -0.44 | -95.39 | 0.23 | |
Capex to revenue | -0.02 | -0.03 | -0.03 | -0.04 | -0.01 | |
Capex to depreciation | -0.62 | -1.21 | -0.78 | -1.28 | -0.21 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.02 | 0.02 | |
Graham number | 1.6 | 1.26 | 1.38 | 0.95 | 3.45 | |
ROIC | 0.3 | 0.19 | 0.11 | 0 | -0.38 | |
Return on tangible assets | 0.19 | 0.1 | 0.08 | 0.01 | -0.33 | |
Graham Net | 0.12 | 0.26 | 0.23 | 0.88 | 0.47 | |
Working capital | 68.66M | 96.41M | 117.16M | 218.05M | 143.19M | |
Tangible asset value | 122.8M | 120.24M | 144.72M | 252.43M | 170.3M | |
Net current asset value | 65.7M | 95.22M | 93.5M | 202.11M | 134.3M | |
Invested capital | 0.07 | 0.03 | 0.16 | 0.09 | 0.14 | |
Average receivables | 0 | 35.86M | 75.08M | 81.35M | 80.47M | |
Average payables | 13.78M | 21.56M | 26.76M | 26.78M | 30.72M | |
Average inventory | 0 | -8.95M | -16.9M | -12.7M | -12.47M | |
Days sales outstanding | 0 | 61.28 | 66.24 | 43.41 | 86.56 | |
Days payables outstanding | 26.84 | 30.05 | 28.41 | 16.28 | 42.7 | |
Days of inventory on hand | 0 | -19.66 | -17.27 | -5.64 | -19.39 | |
Receivables turnover | 0 | 5.96 | 5.51 | 8.41 | 4.22 | |
Payables turnover | 13.6 | 12.15 | 12.85 | 22.43 | 8.55 | |
Inventory turnover | 0 | -18.56 | -21.13 | -64.71 | -18.82 | |
ROE | 0.32 | 0.15 | 0.13 | 0.02 | -0.48 | |
Capex per share | -0.03 | -0.06 | -0.07 | -0.14 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.41 | 0.41 | 0.38 | 0.38 | |
Net income per share | 0 | -0.12 | -0.12 | -0.09 | -0.09 | |
Operating cash flow per share | 0 | -0.03 | -0.03 | -0.02 | -0.02 | |
Free cash flow per share | 0 | -0.03 | -0.03 | -0.02 | -0.02 | |
Cash per share | 0 | 0.83 | 0.83 | 0.81 | 0.81 | |
Book value per share | 0 | 1.05 | 1.05 | 0.83 | 0.83 | |
Tangible book value per share | 0 | 0.92 | 0.92 | 0.71 | 0.71 | |
Share holders equity per share | 0 | 1.05 | 1.05 | 0.83 | 0.83 | |
Interest debt per share | 0 | 0 | 0.15 | 0 | 0.2 | |
Market cap | 0 | 121.24M | 226.42M | 200.84M | 180.45M | |
Enterprise value | -76.72M | -17.33M | 114.33M | 102.63M | 124.11M | |
P/E ratio | 0 | -1.41 | -2.63 | -2.82 | -2.53 | |
Price to sales ratio | 0 | 1.61 | 3 | 2.73 | 2.46 | |
POCF ratio | 0 | -24.75 | -46.21 | -48.61 | -43.67 | |
PFCF ratio | 0 | -22.61 | -42.23 | -46.56 | -41.83 | |
P/B Ratio | 0 | 0.62 | 1.16 | 1.27 | 1.14 | |
PTB ratio | 0 | 0.62 | 1.16 | 1.27 | 1.14 | |
EV to sales | 0 | -0.23 | 1.52 | 1.4 | 1.69 | |
Enterprise value over EBITDA | 0 | 0.81 | -5.12 | -6.09 | -7.37 | |
EV to operating cash flow | 0 | 3.54 | -23.34 | -24.84 | -30.04 | |
EV to free cash flow | 0 | 3.23 | -21.32 | -23.79 | -28.77 | |
Earnings yield | 0 | -0.18 | -0.09 | -0.09 | -0.1 | |
Free cash flow yield | 0 | -0.04 | -0.02 | -0.02 | -0.02 | |
Debt to equity | 0.11 | 0 | 0.14 | 0 | 0.24 | |
Debt to assets | 0.08 | 0 | 0.08 | 0 | 0.13 | |
Net debt to EBITDA | 0 | 6.45 | 5.02 | 5.83 | 3.34 | |
Current ratio | 2.91 | 2.32 | 2.32 | 1.95 | 1.95 | |
Interest coverage | 0 | 0 | -30.65 | 0 | -23.77 | |
Income quality | 0 | 0.23 | 0.23 | 0.23 | 0.23 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.12 | 0.12 | 0.2 | 0.2 | |
Research and developement to revenue | 0 | 0.16 | 0.16 | 0.13 | 0.13 | |
Intangibles to total assets | 0.11 | 0.1 | 0.1 | 0.09 | 0.09 | |
Capex to operating cash flow | 0 | 0.09 | 0.09 | 0.04 | 0.04 | |
Capex to revenue | 0 | -0.01 | -0.01 | 0 | 0 | |
Capex to depreciation | 0 | 1.25 | 1.25 | -0.03 | -0.03 | |
Stock based compensation to revenue | 0 | 0.03 | 0.03 | 0 | 0 | |
Graham number | 0 | 1.65 | 1.65 | 1.32 | 1.32 | |
ROIC | 0 | -0.13 | -0.1 | -0.13 | -0.1 | |
Return on tangible assets | 0 | -0.07 | -0.07 | -0.07 | -0.07 | |
Graham Net | 0 | 0.47 | 0.47 | 0.21 | 0.21 | |
Working capital | 172.29M | 143.19M | 143.19M | 114.02M | 114.02M | |
Tangible asset value | 208.55M | 170.3M | 170.3M | 136.22M | 136.22M | |
Net current asset value | 164.32M | 134.3M | 134.3M | 104.93M | 104.93M | |
Invested capital | 0.11 | 0 | 0.14 | 0 | 0.24 | |
Average receivables | 0 | 38.35M | 76.69M | 66.51M | 56.32M | |
Average payables | 0 | 33.85M | 34.02M | 29.45M | 24.88M | |
Average inventory | 0 | -7.72M | -15.45M | -36.52M | -57.6M | |
Days sales outstanding | 0 | 91.47 | 91.47 | 69 | 69 | |
Days payables outstanding | 0 | 45.13 | 45.13 | 34.98 | 34.98 | |
Days of inventory on hand | 0 | -20.5 | -20.5 | -80.99 | -80.99 | |
Receivables turnover | 0 | 0.98 | 0.98 | 1.3 | 1.3 | |
Payables turnover | 0 | 1.99 | 1.99 | 2.57 | 2.57 | |
Inventory turnover | 0 | -4.39 | -4.39 | -1.11 | -1.11 | |
ROE | 0 | -0.11 | -0.11 | -0.11 | -0.11 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
2159.HK Frequently Asked Questions
What is Mediwelcome Healthcare Management & Technology Inc. stock symbol ?
Mediwelcome Healthcare Management & Technology Inc. is a CN stock and trading under the symbol 2159.HK
What is Mediwelcome Healthcare Management & Technology Inc. stock quote today ?
Mediwelcome Healthcare Management & Technology Inc. stock price is $0.5 today.
Is Mediwelcome Healthcare Management & Technology Inc. stock public?
Yes, Mediwelcome Healthcare Management & Technology Inc. is a publicly traded company.